» Articles » PMID: 33214710

Impact of Prenatal Exome Sequencing for Fetal Genetic Diagnosis on Maternal Psychological Outcomes and Decisional Conflict in a Prospective Cohort

Overview
Journal Genet Med
Publisher Elsevier
Specialty Genetics
Date 2020 Nov 20
PMID 33214710
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To evaluate associations between prenatal trio exome sequencing (trio-ES) and psychological outcomes among women with an anomalous pregnancy.

Methods: Trio-ES study enrolling patients with major fetal anomaly and normal microarray. Women completed self-reported measures and free response interviews at two timepoints: pre- (1) and post- (2) sequencing. Pre-sequencing responses were compared with post-sequencing responses; post-sequencing responses were stratified by women who received trio-ES results that may explain fetal findings, secondary findings (medically actionable or couples with heterozygous variants for the same recessive disorder), or negative results.

Results: One hundred fifteen trios were enrolled. Of those, 41/115 (35.7%) received results from trio-ES, including 36 (31.3%) who received results that may explain the fetal phenotype. These women had greater post-sequencing distress compared with women who received negative results, including generalized distress (p = 0.03) and test-related distress (p = 0.2); they also had worse psychological adaptation to results (p = 0.001). Genomic knowledge did not change from pre- to post-sequencing (p = 0.51).

Conclusion: Women show more distress after receiving trio-ES results compared with those who do not, suggesting that women receiving results may need additional support or counseling to inform current and future reproductive decisions.

Citing Articles

Diagnostic yield and psychological outcomes among women pursuing trio-exome sequencing: Do women with recurrent anomalous fetal phenotypes experience more negative psychological outcomes?.

Talati A, Gilmore K, Hardisty E, Lyerly A, Rini C, Vora N Prenat Diagn. 2023; 43(5):569-578.

PMID: 36690925 PMC: 10176200. DOI: 10.1002/pd.6318.


Implementation of Public Funded Genome Sequencing in Evaluation of Fetal Structural Anomalies.

So P, Hui A, Ma T, Shu W, Hui A, Kong C Genes (Basel). 2022; 13(11).

PMID: 36360323 PMC: 9690018. DOI: 10.3390/genes13112088.


Optimising Exome Prenatal Sequencing Services (EXPRESS): a study protocol to evaluate rapid prenatal exome sequencing in the NHS Genomic Medicine Service.

Hill M, Ellard S, Fisher J, Fulop N, Knight M, Kroese M NIHR Open Res. 2023; 2:10.

PMID: 35935673 PMC: 7613246. DOI: 10.3310/nihropenres.13247.2.


Parental Hopes and Understandings of the Value of Prenatal Diagnostic Genomic Sequencing: A Qualitative Analysis.

Outram S, Brown J, Zamora A, Sahin-Hodoglugil N, Ackerman S Front Genet. 2022; 13:883225.

PMID: 35923691 PMC: 9339950. DOI: 10.3389/fgene.2022.883225.


Can cell-free DNA (cfDNA) testing alleviate psychological distress in early miscarriage? A commentary.

Zayyad S, Liang R, Winkel A, Keefe D, Quinn G J Assist Reprod Genet. 2022; 39(6):1219-1224.

PMID: 35648322 PMC: 9174404. DOI: 10.1007/s10815-022-02489-x.